Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderly


Clinical Trial Description

This clinical trial is conducted to compare the effectiveness and safety between moisturizers containing 0,1% low molecular weight hyaluronic acid, 0,1% high molecular weight hyaluronic acid, and its vehicle on skin hydration of elderly with xerotic skin. It is designed to answer following questions: 1. Is the skin capacitance in the elderly after using moisturizers containing low molecular weight hyaluronic acid higher than high molecular weight hyaluronate acid and vehicle? 2. Is the transepidermal water loss in the elderly after using moisturizers containing high molecular weight hyaluronic acid lower than low molecular weight hyaluronate acid and vehicle? 3. Is the dry skin score (SRRC) in the elderly after using moisturizers containing low molecular weight hyaluronic acid lower than high molecular weight hyaluronate acid and vehicle? 4. Is there any difference in occurence of side effect in elderly between the use of moisturizers containing low molecular weight hyaluronic acid, high molecular weight hyaluronic acid, and vehicle? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06178367
Study type Interventional
Source Indonesia University
Contact
Status Completed
Phase Phase 3
Start date August 26, 2023
Completion date September 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT05046015 - Comparison Dry Foot Skin Between Diabetic and Non-diabetic Subjects and the Effects of Two Cosmetic Foot Care Products N/A
Completed NCT02216526 - Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents N/A
Completed NCT03824886 - Enhancing SKIN Health and Safety in Aged CARE N/A
Completed NCT02557698 - Effectiveness of Using an Oil Bath Additive N/A
Completed NCT03093597 - Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin N/A
Active, not recruiting NCT03815305 - Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2 Phase 4
Recruiting NCT05639933 - Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors Phase 2
Completed NCT04253704 - Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin Phase 1/Phase 2
Completed NCT04127513 - Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis Phase 3